Berlin, Germany

Detlev Suelzle

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Inventor Detlev Suelzle in MRI Technology

Introduction

Detlev Suelzle, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of magnetic resonance imaging (MRI). With a total of 8 patents to his name, his work primarily focuses on gadolinium chelate compounds, which enhance the effectiveness of MRI as a diagnostic tool.

Latest Patents

One of Suelzle's latest patents is centered on a gadolinium chelate compound designed for use in MRI. The patent details a compound having the complex formula: tetragadolinium [4,10-bis(carboxylatomethyl)-7-{-3,6,12,15-tetraoxo-16-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]-9,9-bis({[({2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]propanoyl}amino)acetyl]amino}methyl)-4,7,11,14-tetraazaheptadecan-2-yl}-1,4,7,10-tetraazacyclododecan-1-yl]acetate. The stereochemistry at the chiral carbon of the four alanine substituents can be selected from a variety of stereoisomers, including RRRR, SSSS, RSSS, RRSS, and RRRS, as well as racemic and diastereomeric mixtures. This compound holds potential as an MRI contrast imaging agent, greatly improving imaging quality and diagnostic ability.

Career Highlights

Detlev Suelzle has had a distinguished career, working for reputable companies such as Schering and Bayer Pharma. His experience in these organizations has significantly influenced his research and innovations in imaging technologies. Suelzle’s work has positioned him as a significant figure in the pharmaceutical industry's advancement of diagnostic imaging.

Collaborations

Throughout his career, Suelzle has collaborated with notable colleagues, including Johannes Platzek and Thomas Frenzel. These collaborations have been integral in enhancing research outcomes and driving forward innovations in MRI technology.

Conclusion

In conclusion, Detlev Suelzle's innovative work in the field of gadolinium chelate compounds exemplifies the critical role of inventors in advancing medical technology. His patents reflect a commitment to improving diagnostic capabilities through enhanced MRI techniques, showcasing his status as a leading inventor in the medical imaging sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…